Rare Cancers
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| TCF-001 TRACK (Target Rare Cancer Knowledge) Study (NCT04504604) | TargetCancer Foundation | 2020-10-01 |
| Molecularly Aided Stratification for Tumor Eradication Research (NCT05852522) | German Cancer Research Center | 2018-11-11 |
| Dabrafenib and/or Trametinib Rollover Study (NCT03340506) | Novartis Pharmaceuticals | 2018-01-26 |
| Integrated Molecular Profiling in Advanced Cancers Trial (NCT01505400) | University Health Network, Toronto | 2012-02-01 |
Track Rare Cancers automatically
Every clearance here is in the API, with alerts when new ones post.